{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:41:28Z","timestamp":1793572888519,"version":"4.5.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200205\/Z\/15\/Z"],"award-info":[{"award-number":["200205\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1133541"],"award-info":[{"award-number":["OPP1133541"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Oxford Biomedical Research Centre","id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance","id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203919\/Z\/16\/Z"],"award-info":[{"award-number":["203919\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018536","name":"National Mega Project on Major Infectious Disease Prevention","doi-asserted-by":"publisher","award":["2018ZX10103001"],"award-info":[{"award-number":["2018ZX10103001"]}],"id":[{"id":"10.13039\/501100018536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["EIPOD3"],"award-info":[{"award-number":["EIPOD3"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Unitaid","award":["2019-32-FIND MDR"],"award-info":[{"award-number":["2019-32-FIND MDR"]}],"id":[{"id":"https:\/\/ror.org\/05t99je22","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["17\/16082-7"],"award-info":[{"award-number":["17\/16082-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2012\/51756-5"],"award-info":[{"award-number":["2012\/51756-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81991534"],"award-info":[{"award-number":["81991534"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z201100005520041"],"award-info":[{"award-number":["Z201100005520041"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust International Intermediate Fellowship","award":["206724\/Z\/17\/Z"],"award-info":[{"award-number":["206724\/Z\/17\/Z"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Rhodes Trust and Stanford Medical Scientist Training Program","award":["T32 GM007365"],"award-info":[{"award-number":["T32 GM007365"]}],"id":[{"id":"https:\/\/ror.org\/04v48nr57","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections at Imperial College London","id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fonds de Recherche en Sant\u00e9 du Qu\u00e9bec"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203583\/Z\/16\/Z"],"award-info":[{"award-number":["203583\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","award":["G0F8316N"],"award-info":[{"award-number":["G0F8316N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["98316"],"award-info":[{"award-number":["98316"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214321\/Z\/18\/Z"],"award-info":[{"award-number":["214321\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation South Africa","award":["64787"],"award-info":[{"award-number":["64787"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["201470\/Z\/16\/Z"],"award-info":[{"award-number":["201470\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI146338"],"award-info":[{"award-number":["1R01AI146338"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GOSH","award":["1R01AI146338"],"award-info":[{"award-number":["1R01AI146338"]}]},{"name":"GOSH\/ICH Biomedical Research Centre"},{"name":"Oxford Medical Research Council Doctoral Training Partnership","award":["NDM Prize Studentship"],"award-info":[{"award-number":["NDM Prize Studentship"]}]},{"name":"Nuffield Department of Clinical Medicine"},{"name":"Sir Henry Dale Fellowship","award":["101237\/Z\/13\/B"],"award-info":[{"award-number":["101237\/Z\/13\/B"]}]},{"name":"The Robertson Foundation","id":[{"id":"https:\/\/ror.org\/04h2x1077","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214560\/Z\/18\/Z"],"award-info":[{"award-number":["214560\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rhodes Trust","id":[{"id":"https:\/\/ror.org\/04v48nr57","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC0010218"],"award-info":[{"award-number":["FC0010218"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["FC0010218"],"award-info":[{"award-number":["FC0010218"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC0010218"],"award-info":[{"award-number":["FC0010218"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203141\/Z\/16\/Z"],"award-info":[{"award-number":["203141\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC BRC-1215-20008"],"award-info":[{"award-number":["BRC BRC-1215-20008"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Health Scotland","id":[{"id":"https:\/\/ror.org\/023wh8b50","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U60OE000103"],"award-info":[{"award-number":["U60OE000103"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI-117312"],"award-info":[{"award-number":["AI-117312"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"abstract":"<jats:p>\n                    The Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) presents here a data compendium of 12,289\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    global clinical isolates, all of which have undergone whole-genome sequencing and have had their minimum inhibitory concentrations to 13 antitubercular drugs measured in a single assay. It is the largest matched phenotypic and genotypic dataset for\n                    <jats:italic>M<\/jats:italic>\n                    .\n                    <jats:italic>tuberculosis<\/jats:italic>\n                    to date. Here, we provide a summary detailing the breadth of data collected, along with a description of how the isolates were selected, collected, and uniformly processed in CRyPTIC partner laboratories across 23 countries. The compendium contains 6,814 isolates resistant to at least 1 drug, including 2,129 samples that fully satisfy the clinical definitions of rifampicin resistant (RR), multidrug resistant (MDR), pre-extensively drug resistant (pre-XDR), or extensively drug resistant (XDR). The data are enriched for rare resistance-associated variants, and the current limits of genotypic prediction of resistance status (sensitive\/resistant) are presented by using a genetic mutation catalogue, along with the presence of suspected resistance-conferring mutations for isolates resistant to the newly introduced drugs bedaquiline, clofazimine, delamanid, and linezolid. Finally, a case study of rifampicin monoresistance demonstrates how this compendium could be used to advance our genetic understanding of rare resistance phenotypes. The data compendium is fully open source and it is hoped that it will facilitate and inspire future research for years to come.\n                  <\/jats:p>","DOI":"10.1371\/journal.pbio.3001721","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:01:07Z","timestamp":1660053667000},"page":"e3001721","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":122,"title":["A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics"],"prefix":"10.1371","volume":"20","author":[{"name":"The CRyPTIC Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"pbio.3001721.ref001","author":"WHO","year":"2021","journal-title":"Global Tuberculosis Report 2020"},{"key":"pbio.3001721.ref002","unstructured":"World Health Organisation. EndTB Campaign. Available from: www.who.int\/teams\/global-tuberculosis-programme\/the-end-tb-strategy."},{"key":"pbio.3001721.ref003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737159.2015.976556","article-title":"Evaluation of the Cepheid Xpert MTB\/RIF assay","volume":"15","author":"TM Shinnick","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"pbio.3001721.ref004","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"CC Boehme","year":"2011","journal-title":"Lancet"},{"key":"pbio.3001721.ref005","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","volume":"18","author":"NA Makhado","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pbio.3001721.ref006","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13073-020-00793-8","article-title":"MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era","volume":"12","author":"P Beckert","year":"2020","journal-title":"Genome Med"},{"key":"pbio.3001721.ref007","first-page":"1181","article-title":"Detection of Drug-Resistant Tuberculosis by Xpert MTB\/RIF in Swaziland, New England.","volume":"372","author":"E Sanchez-Padilla","year":"2015","journal-title":"J Med"},{"key":"pbio.3001721.ref008","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.","volume":"379","author":"The CRyPTIC Consortium","year":"2018","journal-title":"N Engl J Med"},{"key":"pbio.3001721.ref009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","article-title":"Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study","volume":"4","author":"LJ Pankhurst","year":"2016","journal-title":"Lancet Respir Med"},{"key":"pbio.3001721.ref010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MAJ.0b013e31825d32c6","article-title":"Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing","volume":"345","author":"AS Kalokhe","year":"2013","journal-title":"Am J Med Sci"},{"key":"pbio.3001721.ref011","first-page":"62","article-title":"Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis","author":"PM v Rancoita","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3001721.ref012","doi-asserted-by":"crossref","first-page":"2200239","DOI":"10.1183\/13993003.00239-2022","article-title":"Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.","author":"The CRyPTIC Consortium","year":"2022","journal-title":"Eur Respir J"},{"key":"pbio.3001721.ref013","article-title":"Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.","author":"The CRyPTIC Consortium","year":"2021","journal-title":".bioRxiv"},{"key":"pbio.3001721.ref014","unstructured":"The CRyPTIC Consortium. Predicting Susceptibility to First- and Second-line Tuberculosis Drugs by DNA sequencing and Machine Learning. In preparation."},{"key":"pbio.3001721.ref015","article-title":"Genome-wide association studies of global Mycobacterium tuberculosis resistance to thirteen antimicrobials in 10,228 genomes.","author":"The CRyPTIC Consortium","year":"2021","journal-title":".bioRxiv"},{"key":"pbio.3001721.ref016","article-title":"Deciphering Bedaquiline and Clofazimine Resistance in Tuberculosis. An Evolutionary Medicine Approach.","author":"L Sonnenkalb","year":"2021","journal-title":"bioRxiv"},{"key":"pbio.3001721.ref017","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.smim.2014.09.012","article-title":"Consequences of genomic diversity in Mycobacterium tuberculosis","volume":"26","author":"M Coscolla","year":"2014","journal-title":"Semin Immunol"},{"key":"pbio.3001721.ref018","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","article-title":"Ecology and evolution of Mycobacterium tuberculosis","volume":"16","author":"S. Gagneux","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"pbio.3001721.ref019","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1038\/s41467-021-26248-1","article-title":"Population structure, biogeography and transmissibility of Mycobacterium tuberculosis.","volume":"12","author":"L Freschi","year":"2021","journal-title":"Nat Commun"},{"key":"pbio.3001721.ref020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01724-17","article-title":"In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin","volume":"62","author":"JA Dijkstra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3001721.ref021","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/jac\/dkx150","article-title":"Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis","volume":"72","author":"T Maitre","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"pbio.3001721.ref022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2016.01.019","article-title":"Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex","volume":"85","author":"ZL Berrada","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pbio.3001721.ref023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2014.03.1388","article-title":"Fluoroquinolone resistance in non-multidrug-resistant tuberculosis\u2014a surveillance study in New South Wales, Australia, and a review of global resistance rates","volume":"26","author":"J Ho","year":"2014","journal-title":"Int J Infect Dis"},{"key":"pbio.3001721.ref024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12688\/wellcomeopenres.15603.1","article-title":"Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe","volume":"4","author":"M Hunt","year":"2019","journal-title":"Wellcome Open Res"},{"key":"pbio.3001721.ref025","article-title":"The 2021 WHO Catalogue of Mycobacterium Tuberculosis Complex Mutations Associated with Drug Resistance: A New Global Standard for Molecular Diagnostics.","author":"TM Walker","year":"2021","journal-title":"SSRN Electronic Journal"},{"key":"pbio.3001721.ref026","doi-asserted-by":"crossref","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","article-title":"A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis","volume":"50","author":"P Miotto","year":"2017","journal-title":"Eur Respir J"},{"issue":"322","key":"pbio.3001721.ref027","first-page":"1392","article-title":"PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release","volume":"2008","author":"R Singh","year":"1979","journal-title":"Science"},{"key":"pbio.3001721.ref028","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"RC Hartkoorn","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3001721.ref029","doi-asserted-by":"crossref","first-page":"559469","DOI":"10.3389\/fmicb.2020.559469","article-title":"In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates","volume":"11","author":"G Degiacomi","year":"2020","journal-title":"Front Microbiol"},{"key":"pbio.3001721.ref030","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1128\/AAC.00753-16","article-title":"Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis","volume":"60","author":"D Almeida","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3001721.ref031","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S2666-5247(20)30031-8","article-title":"Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis","volume":"1","author":"C Nimmo","year":"2020","journal-title":"Lancet Microbe"},{"key":"pbio.3001721.ref032","doi-asserted-by":"crossref","first-page":"e031663","DOI":"10.1136\/bmjopen-2019-031663","article-title":"Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis","volume":"9","author":"NR Mvelase","year":"2019","journal-title":"BMJ Open"},{"key":"pbio.3001721.ref033","doi-asserted-by":"crossref","first-page":"e0152933","DOI":"10.1371\/journal.pone.0152933","article-title":"Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.","volume":"11","author":"L Villegas","year":"2016","journal-title":"PLoS ONE"},{"key":"pbio.3001721.ref034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rmed.2017.08.002","article-title":"Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis","volume":"131","author":"S Park","year":"2017","journal-title":"Respiratory Medicine"},{"key":"pbio.3001721.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00364-21","article-title":"Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa","volume":"65","author":"Z Salaam-Dreyer","year":"2021","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pbio.3001721.ref036","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/AAC.01024-12","article-title":"Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis","volume":"57","author":"Y Pang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3001721.ref037","doi-asserted-by":"crossref","first-page":"e0198091","DOI":"10.1371\/journal.pone.0198091","article-title":"Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda","volume":"13","author":"E Kigozi","year":"2018","journal-title":"PLoS ONE"},{"key":"pbio.3001721.ref038","doi-asserted-by":"crossref","first-page":"e1003008","DOI":"10.1371\/journal.pmed.1003008","article-title":"Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data","volume":"17","author":"AS Dean","year":"2020","journal-title":"PLoS Med"},{"key":"pbio.3001721.ref039","doi-asserted-by":"crossref","first-page":"1701778","DOI":"10.1183\/13993003.01778-2017","article-title":"Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh","volume":"51","author":"SK Heysell","year":"2018","journal-title":"Eur Respir J"},{"key":"pbio.3001721.ref040","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1183\/09031936.00036812","article-title":"Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones","volume":"40","author":"GB Migliori","year":"2012","journal-title":"Eur Respir J"},{"key":"pbio.3001721.ref041","article-title":"Update on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication.","author":"WHO","year":"2021","journal-title":"."},{"key":"pbio.3001721.ref042","doi-asserted-by":"crossref","first-page":"1700742","DOI":"10.1183\/13993003.00742-2017","article-title":"Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis","volume":"49","author":"ID Olaru","year":"2017","journal-title":"Eur Respir J"},{"key":"pbio.3001721.ref043","article-title":"World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update","author":"WHO","year":"2016","journal-title":"."},{"key":"pbio.3001721.ref044","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/AAC.01611-09","article-title":"Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor","volume":"54","author":"E Huitric","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3001721.ref045","first-page":"1522","article-title":"Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis","volume":"164","author":"PW Fowler","year":"2018","journal-title":"Microbiology (N Y)."},{"key":"pbio.3001721.ref046","article-title":"BashTheBug: a crowd of volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates.","author":"PW Fowler","year":"2021","journal-title":"bioRxiv."},{"key":"pbio.3001721.ref047","article-title":"Minos: variant adjudication and joint genotyping of cohorts of bacterial genomes.","author":"M Hunt","year":"2021","journal-title":"bioRxiv."},{"key":"pbio.3001721.ref048","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"key":"pbio.3001721.ref049","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"AM Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"pbio.3001721.ref050","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"key":"pbio.3001721.ref051","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.1028","article-title":"De novo assembly and genotyping of variants using colored de Bruijn graphs","volume":"44","author":"Z Iqbal","year":"2012","journal-title":"Nat Genet"},{"key":"pbio.3001721.ref052","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2213-2600(14)70027-X","article-title":"Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007\u201312, with whole pathogen genome sequences: an observational study.","volume":"2","author":"TM Walker","year":"2014","journal-title":"Lancet Respir Med"},{"key":"pbio.3001721.ref053","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/bioinformatics\/18.11.1546","article-title":"QuickTree: building huge Neighbour-Joining trees of protein sequences","volume":"18","author":"K Howe","year":"2002","journal-title":"Bioinformatics"},{"key":"pbio.3001721.ref054","article-title":"Using ggtree to Visualize Data on Tree-Like Structures","volume":"69","author":"G. Yu","year":"2020","journal-title":"Curr Protoc Bioinform"}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3001721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T12:18:27Z","timestamp":1660565907000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3001721"}},"subtitle":[],"editor":[{"given":"Jason","family":"Ladner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3001721","relation":{},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}